Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study-Reference-Cited by-同舟云学术

Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study

Published:2024-04-20 Issue:6 Volume:43 Page:1971-1978
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Rivero-Gallegos Daphne,Mejía Mayra,Rocha-González Héctor I.,Huerta-Cruz Juan C.,Falfán-Valencia Ramcés,Ramos-Martínez Espiridion,Mateos-Toledo Heidegger N.,Castillo-López María F.,Rodríguez-Torres Yeimi K.,Lira-Boussart Valeria,Rojas-Serrano Jorge^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10067-024-06965-w.pdf

Reference27 articles.

1. Galindo-Feria AS, Notarnicola A, Lundberg IE, Horuluoglu B (2022) Aminoacyl-tRNA synthetases: on anti-synthetase syndrome and beyond. Front Immunol 13. https://doi.org/10.3389/FIMMU.2022.866087

2. Ghirardello A, Doria A (2018) New insights in myositis-specific autoantibodies. Curr Opin Rheumatol 30:614–622. https://doi.org/10.1097/BOR.0000000000000548

3. Betteridge Z, Tansley S, Shaddick G, et al (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun 101. https://doi.org/10.1016/j.jaut.2019.04.001.

4. Cavagna L, Trallero-Araguás E, Meloni F, et al (2019) Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course. J Clin Med 8: https://doi.org/10.3390/JCM8112013

5. Opinc AH, Makowska JS (2021) Antisynthetase syndrome – much more than just a myopathy. Semin Arthritis Rheum 51:72–83. https://doi.org/10.1016/J.SEMARTHRIT.2020.09.020